metoprolol has been researched along with simendan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Algotsson, L; Liao, Q; Linnér, R; Metzsch, C; Steen, S | 1 |
| Graudins, A; Kalam, Y | 1 |
| Autschbach, R; Bernhagen, J; Bleilevens, C; Goetzenich, A; Hatam, N; Moza, A; Preuss, S; Roehl, AB; Stoppe, C | 1 |
3 other study(ies) available for metoprolol and simendan
| Article | Year |
|---|---|
Levosimendan cardioprotection in acutely beta-1 adrenergic receptor blocked open chest pigs.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Clinical Protocols; Female; Glucose; Glycerol; Hemodynamics; Hydrazones; Lactic Acid; Male; Metoprolol; Microdialysis; Myocardial Ischemia; Myocardial Reperfusion Injury; Pyridazines; Pyruvic Acid; Simendan; Swine; Thoracic Surgical Procedures; Treatment Outcome | 2010 |
Levosimendan infusion improves cardiac output but not blood pressure in a rodent model of severe metoprolol toxicity.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Heart; Heart Diseases; Hydrazones; Male; Metoprolol; Pyridazines; Rats; Rats, Wistar; Simendan; Vasodilator Agents | 2012 |
The role of hypoxia-inducible factor-1α and vascular endothelial growth factor in late-phase preconditioning with xenon, isoflurane and levosimendan in rat cardiomyocytes.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Animals, Newborn; Cell Hypoxia; Cell Survival; Cells, Cultured; Cytoprotection; Hydrazones; Hypoxia-Inducible Factor 1, alpha Subunit; Isoflurane; Metoprolol; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Pyridazines; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Simendan; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A; Xenon | 2014 |